Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial.
- DOI
- 10.1001/jamaophthalmol.2025.5098
- Published
- 2026 Feb 1
- Container
- JAMA ophthalmology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1001/jamaophthalmol.2025.5098,
title = {Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial.},
author = {Lee WK and Wong TY and Chen SJ and Sun X and Cheung CMG and Silva R and Ricci F and Zhang X and Machewitz T and Schulze A and Schmidt-Ott UM and Zhao M and Hasanbasic Z and Leal S and Iida T and PULSAR Study Investigators},
year = {2026},
journal = {JAMA ophthalmology},
doi = {10.1001/jamaophthalmol.2025.5098},
url = {https://doi.org/10.1001/jamaophthalmol.2025.5098}
}RIS
TY - JOUR TI - Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial. AU - Lee WK AU - Wong TY AU - Chen SJ AU - Sun X AU - Cheung CMG AU - Silva R AU - Ricci F AU - Zhang X AU - Machewitz T AU - Schulze A AU - Schmidt-Ott UM AU - Zhao M AU - Hasanbasic Z AU - Leal S AU - Iida T AU - PULSAR Study Investigators PY - 2026 JO - JAMA ophthalmology DO - 10.1001/jamaophthalmol.2025.5098 UR - https://doi.org/10.1001/jamaophthalmol.2025.5098 ER -
APA
WK, L., TY, W., SJ, C., X, S., CMG, C., R, S., F, R., X, Z., T, M., A, S., UM, S., M, Z., Z, H., S, L., T, I., & Investigators, P. S. (2026). Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial.. JAMA ophthalmology. https://doi.org/10.1001/jamaophthalmol.2025.5098
Source records
- pubmed · retrieved 2026-09-27T00:46:28.902Z